This inventor holds 1 USPTO granted patent. Top assignee: Deep Genomics Incorporated. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Frank Schmitges: Innovator in Oligonucleotide Therapy
Introduction
Frank Schmitges is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapies for genetic disorders. His work focuses on innovative solutions that address complex medical challenges.
Latest Patents
Frank Schmitges holds a patent for "Oligonucleotide therapy for Wilson disease." This patent provides antisense oligonucleotides, compositions, and methods that target ATP7B exon 6 or a flanking intron. The goal is to modulate splicing of ATP7B pre-mRNA to increase the level of ATP7B mRNA molecules having exon 6. This innovation aims to provide a therapy for Wilson disease, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Frank has demonstrated a strong dedication to research and development. He is currently associated with Deep Genomics Incorporated, where he continues to explore groundbreaking therapeutic approaches. His work has the potential to significantly impact the treatment of Wilson disease and similar genetic conditions.
Collaborations
Frank collaborates with talented individuals in his field, including Daniele Merico and Erno Wienholds. These partnerships enhance the research environment and foster innovation in therapeutic development.
Conclusion
Frank Schmitges is a pioneering inventor whose work in oligonucleotide therapy represents a significant advancement in the treatment of genetic disorders. His contributions to biotechnology continue to inspire and drive progress in the medical field.